Skip to content

McKesson MCK Gross Profit

Gross Profit at other companies

Eli Lilly logo
Eli LillyLLY
$16.22B+54.4%
Cardinal Health logo
Cardinal HealthCAH
$2.5B+17.7%
Cencora logo
CencoraCOR
$3.59B+17.3%
AbbVie logo
AbbVieABBV
$10.78B+15.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$320.11M+25.1%
Viatris logo
ViatrisVTRS
$1.16B-0.3%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$89.43B-0.8%
Enterprise value$87.73B-5.7%
P/E18.8×-8.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Calculated from McKesson’s reported figures.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's gross profit?
McKesson (MCK) reported gross profit of $4.04B in Q1 2026.
How has McKesson's gross profit changed year-over-year?
McKesson's gross profit increased by 11.1% year-over-year, from $3.64B to $4.04B.
What is the long-term trend for McKesson's gross profit?
Over 4 years (2022 to 2026), McKesson's gross profit has grown at a 2.6% compound annual growth rate (CAGR), from $13.13B to $14.55B.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.